Actively Recruiting
High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-03-03
124
Participants Needed
8
Research Sites
74 weeks
Total Duration
On this page
Sponsors
I
Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor
A
Azienda Ospedaliero-Universitaria di Modena
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is determine if a high-tech rehabilitation circuit is more effective than usual rehabilitation methods in improving functional outcome, particularly balance control, for patients with acute neuromuscolar diseases. The main question it aims to answer is: Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, more effective than traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with acute neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.
CONDITIONS
Official Title
High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 80 years
- Confirmed diagnosis of acute or subacute neuromuscular diseases such as Guillain-Barré Syndrome, Critical Illness Myopathy, or Critical Illness Polyneuropathy
- Disease onset between 15 and 30 days prior to enrollment
- Lower limb muscle strength of 2 or more on the Medical Research Council scale in at least two of the flexor and extensor muscles of the hip, knee, and ankle joints
- Ability to provide informed consent
You will not qualify if you...
- Unstable medical conditions that could interfere with safe participation, including severe cardiovascular diseases (NYHA class 4) or uncompensated respiratory distress
- Participation in other clinical trials that might interfere with this study
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Istituti Clinici Scientifici Maugeri
Bari, Italy, 70124
Not Yet Recruiting
2
IRCCS Azienda Ospedaliera Universitaria San Martino - Genova
Genova, Italy, 16132
Not Yet Recruiting
3
Istituti Clinici Scientifici Maugeri IRCCS, Milan Institute
Milan, Italy, 20138
Actively Recruiting
4
Azienda Ospedaliero-Universitaria di Modena
Modena, Italy, 41126
Not Yet Recruiting
5
Istituti Clinici Scientifici Maugeri
Montescano, Italy, 27040
Not Yet Recruiting
6
Istituti Clinici Scientifici Maugeri
Pavia, Italy, 27100
Not Yet Recruiting
7
Fondazione Don Carlo Gnocchi Onlus
Roma, Italy, 00135
Not Yet Recruiting
8
Istituti Clinici Scientifici Maugeri
Telese Terme, Italy, 82037
Not Yet Recruiting
Research Team
C
Christian Lunetta, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here